This week is Vestibular Disorders's #BalanceAwarenessWeek. Otolith is a proud sponsor of VeDa and recognizes this week as a great opportunity to spread awareness about the millions of people suffering from chronic #vertigo and #vestibular disorders. Learn more: lnkd.in/ej3-qDHn

Thank you to Otolith Labs’ investor @MCuban for investing in Otolith and giving us the foundation to continue growing and raise $20M in Series A funding this year. Each step has helped Otolith in the development of a life-changing medical wearable device for chronic #vertigo.

We are thrilled that Otolith Labs Founder and CEO Sam Owen, Chief Business Officer Tom Hardart, and Chief Product Officer Jon Akers are attending The MedTech Conference in Boston! Otolith is excited to connect with industry leaders over the next few days. #MedTechCon #MTC22

Next week, Otolith Labs' Founder and CEO Sam Owen is presenting at the MedTech Strategist | MedTech's Most Trusted Source Innovation Summit in SF for the second year in a row. Otolith is looking forward to discussing our groundbreaking technology with #MedTech industry leaders. Hope to see you there! #InnovationSF22

Sam Owen, Otolith Labs' Founder and CEO, presents at the MedTech Strategist | MedTech's Most Trusted Source Innovation Summit SF 2022 about Otolith's FDA Breakthrough Designated technology currently being developed to treat chronic #vertigo. #InnovationSF22 #medtech Learn more below:

Our partner Vestibular Disorders has useful resources for people suffering from chronic #vertigo and #vestibular disorders. Patient Spotlights is a place to read the stories of others who know what you're going through and share your vestibular journey. Visit Vestibular.org/spotlight.

Otolith Labs is proud to announce the formation of our Medical Advisory Board! Please join us in welcoming leaders in the #otolaryngology community: Jeffrey Sharon, MD, Kristen Steenerson, MD, Michael Hoffer, MD, Steven Eliades, MD, PhD, and Hinrich Staecker, MD, PhD.

Otolith Labs’ Chief Science Officer Didier Depireux, PhD, and Senior Research Scientist Daniel Stolzberg, PhD, are presenting Otoltih’s Vertigo Study results on a scientific poster at ARO's 46th Annual MidWinter Meeting this week. Hope to see you there! #ARO2023 #vertigo

Otolith Labs' Founder and CEO Sam Owen has been selected by LSI - Life Science Intelligence™ to present at #LSIUSA23, medtech's premier partnering event! If you're attending, make sure to connect with Sam Owen in Dana Point, CA next week, March 20-23, 2023. #medtech #LSIAlumni

Otolith is excited to introduce Michael E Hoffer, MD, a member of our #MedicalAdvisoryBoard! As a distinguished Professor of Otolaryngology and Neurological Surgery at UMiami, Dr. Hoffer brings extensive experience and knowledge to our team. Extended bio: lnkd.in/eZE5UEnV

Exciting News! Otolith Labs is now enrolling in a new At-home Vertigo Study! It's a paid research study that can be completed from home. Enrollment will be limited, so enroll now to secure your spot. See if you are eligible and learn more here: lnkd.in/etCKk7eR #vertigo

We're honored to introduce another member of our #MedicalAdvisoryBoard, Jeffrey Sharon, MD! At UCSF, Dr. Sharon is an Associate Professor of Otology, Neurotology, and Skull Base Surgery, as well as the Director of the Balance and Falls Center. Read more: lnkd.in/e6xrdVWn

We are highlighting Otolith Labs’ Clinical Coordinator II, Kevin Grant! He joined our clinical team last spring and plays a vital role in our vertigo study, working with study participants and collecting study data. We are very excited to have Kevin on our team! #teamspotlight

On Sept. 9, Otolith Labs' Chief Science Officer Didier Depireux, PhD, will be presenting at the 8th International Congress on Bone Conduction Hearing and Related Technologies in Denver, CO! See you there. #OSSEO2023 #vertigo #vertigostudy #boneconduction

Meet us at #OTOMTG23 at Booth 2400! Otolith Labs is thrilled to be exhibiting at AmAcadOtolaryngology's Annual Meeting from Sept 30-Oct 4. Stop by our booth to learn more about clinician involvement in our #vertigo study, see our product, and meet our team. See you in Nashville! #AAOHNSF

Otolith Labs is at #OTOMTG23! Come visit us at Booth 2400 to learn more about clinician involvement in our upcoming #vertigo study, see our device, and meet our team! AmAcadOtolaryngology #vestibular #otolaryngology

Welcome to the team, Dan Wagner! Otolith grows its experience by adding Dan’s 17 years of executive and #medtech leadership. As Otolith’s CCO, Dan is spearheading Otolith's go-to-market plan and more... Continue reading the press release here: lnkd.in/eKsapx_F

Meet us in San Francisco at @WilsonSonsini's #MDC2024! Contact Sam Owen if you are attending. We're eager to share the latest updates on major milestones at Otolith, study results, and demonstrate our breakthrough #wearable device in development for treating chronic #vertigo.

Otolith Labs is honored to announce we have joined the Vestibular Disorders's Industry Advisory Council! Otolith Labs is a proud sponsor of VeDa and is excited about this opportunity to collaborate further to support vestibular patients worldwide. More here: lnkd.in/eVPrpC7r